• Langley Road, Brighton, MA
  • 416-402-8274


Input Your Idea or Solution

Have you been working on a fantastic new technology that may be a game-changer in Alzheimer’s management, treatment or diagnosis? Submit it here!

Contact us if you would like to learn more and/or invest in these great solutions:

Treatment for Alzheimer’s Disease:

* A dialysis-type system for filtering out the harmful proteins (A-Beta, Tau) from Cerebrospinal Fluid (CSF) that accumulate in the brain and cause the cascade of events that lead to Alzheimer’s Disease.

* Using RNA sequencing (genetic testing) to identify therapeutic targets that may yield a blood-based biomarker that can be used to monitor treatment efficacy.

* Synthetic organic methodology with enantioselective drugs to treat Alzheimer’s Disease

* A new drug, originally developed to treat diabetes, that can create a cognitive improvement in Alzheimer’s Disease patients.

* The development of cell models for the rapid screening of drugs for their effects on the synthesis of certain proteins in the neurons.

* Using advanced mathematical models to cure the disease.

* Using yeast to model aging cells and test biochemicals that improve the turnover of amyloid beta.

* Using newly discovered soluble receptors for certain proteins to establish the bio-activity of the hormones.

* Using new information about lysosomes to decrease proteins at nerve receptors (where information is usually lost in Alzheimer’s patients).

Diagnosis of Alzheimer’s Disease:

* A new type of Virtual Scanning technology that can determine the broad range of pathologies which characterize Alzheimer’s Disease.

* New insights into using erythrocytes (type of blood cell) to determine Alzheimer’s Disease diagnosis.

* Using SNPs (single nucleotide polymorphisms – small changes in the DNA) to diagnose Alzheimer’s Disease.

* Using hyperpolarized MRI and stable isotope chemistry to create a non-invasive, non-ionizing, neuroimaging technique to diagnose ALZ at a very early stage.

Management of Alzheimer’s Disease:

*  Using trans-cranial alternating current as a means to manage Alzheimer’s Disease.

* Looking at levels of AchE in the blood to determine the levels of toxicity that cause memory loss.

Sign the petition

You can add formatting using markdown syntax - read more
139 signatures = 14% of goal

Share this with your friends:


Latest Signatures
139 Ms Jeremy A. United States Apr 07, 2021
138 Ms Corrine W. United States Minor Outlying Islands Mar 15, 2021
137 Ms Moises P. United States Minor Outlying Islands Jan 31, 2021
136 Ms Boyd B. United States Minor Outlying Islands Dec 20, 2020
135 Ms Mae R. United States Minor Outlying Islands Dec 17, 2020